Limited $450,000 funding opportunity for Stanford faculty with UTL, UML, and NTLR appointments. These grants foster promising breast cancer researchers who are in the early stages of their faculty careers by providing support for up to three years of “protected time” for research career development. Komen seeks to support those who will emerge as the next key leaders in the fight against breast cancer. A university-wide internal selection process is required.
Number of applicants permitted per institution: 2
Each invited institution may submit one nominee to apply. A second nominee may be submitted (if that nominee identifies as someone from a racial or ethnic group that is underrepresented in the US biomedical research workforce as defined by the NIH) – “Blacks or African Americans, Hispanics or Latinos, American Indians or Alaska Natives, Native Hawaiians and other Pacific Islanders”)
Timeline:
Internal Stanford Cancer Institute deadline: July 28, 2021 (see internal submission guidelines below)
Stanford Cancer Institute will notify the applicant selected that he/she will be nominated: August 2, 2021
For the selected candidates:
Letter of Intent (LOI) deadline: August 18, 2021, by 1 p.m., Eastern Standard Time
Institutional representative (RPM/RMG or CGO/OSR) deadline: October 8, 2021
Sponsor deadline: October 13, 2021, by 1 p.m., Eastern Standard Time
Guidelines:
Full instructions for the Letter of Intent.
Amount of funding:
Applicants/PIs may request funding of up to $150,000 per year (combined direct and indirect costs) for up to three years ($450,000).
2021-2022 (FY22) Career Catalyst Research Topic: Redefining Metastatic Breast Cancer
The goal of the FY22 CCR Grant is to support innovative approaches that seek to answer critical questions focused on conquering metastatic breast cancer. Letters of Intent that lack a significant focus on metastatic breast cancer will be administratively withdrawn. Komen considers innovative to be employing new thinking, new methods, new strategies to make a substantial, non-incremental step forward in our understanding of the biology of metastatic breast cancer and/or how we prevent, detect, or treat MBC. We encourage applicants to build ground-breaking paradigms, test imaginative hypotheses and investigate creative concepts that may challenge the current prevailing theories or practices. See program guidelines for focus areas.
Eligibility:
Stanford faculty with PI eligibility (UTL, UML, and NTRL appointments) may apply.
Applicants for the 2022 award must:
- Must currently hold a full-time faculty appointment or have a formal offer letter from the Institution that confirms position and start date by the Application due date (October 13, 2021), documented by the Applicant/PI Biosketch and Letter of Institutional Support.
- Must not have held any faculty appointment, including non-tenure and tenure track appointments combined, for more than a total of 8 years by the Application due date (October 13, 2021), documented by the Applicant/PI Biosketch and Letter of Institutional Support. All positions that are considered as “Faculty” positions by the Applicant/PI’s institution (or prior institution) count towards the 8-year limit.
- Must not simultaneously hold any other Grant awarded by Susan G. Komen.
- Must not currently be or have been a Principal Investigator on an existing NIH R01 grant or their equivalent as of the date of Award Notification (on or around April 15, 2022).
- See program guidelines for additional requirments.
STANFORD INTERNAL SUBMISSION GUIDELINES
By July 28, 2021, please submit one PDF file containing the following, in the order listed below, via email attachment to:
Gayle White
Stanford Cancer Institute
gwhite5@stanford.edu
File name: Last name_Komen_CCR.pdf
Institutional representative: not applicable. You do not need to submit your internal proposal through your institutional official for approval. You may submit your internal proposal directly to Gayle White.
1) Title Page
Komen Career Catalyst Research (CCR) Grants
Title of proposal
PI contact information: (name, title, department, address, email)
Confirmation of whether or not the PI represents an underrepresented population in Biomedical Research workforce as defined by the NIH) – “Blacks or African Americans, Hispanics or Latinos, American Indians or Alaska Natives, Native Hawaiians and other Pacific Islanders”
2) 3 page research proposal
Please include an Innovation and Impact Statement per the program guidelines.
Format: Arial 11 font, single-spaced, 1 inch margins). References and figures are not included in the page limit.
3) PI NIH format biosketch
Selection process:
Proposals will be reviewed by a Stanford Cancer Institute review committee. That committee will select the applicants to represent Stanford.
